Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (786)	1/4/2000 4:56:00 PM
From: celeryroot.com	Read Replies (1) \| Respond to of 4474

" "ARIAD is very pleased with its relationship with Brown Simpson Asset Management and looks forward to the potential of working with Brown Simpson again in the future," said Dr. Berger." from pr release wellllllllllllllllllllll

To: Biomaven who wrote (786)	1/4/2000 7:10:00 PM
From: LLCF	Respond to of 4474

<I suspect the daytraders just went wild.... Alternatively, could be Promethean (the remaining convertible holders) suddenly decided to cover their (admitted) short on the open market. I'd be surprised if this is what's happening> Peter if this is true, I think we've got a hell of a year in front of us. :) I'm a little suspicious though, I mean there are daytraders out there punting away on esoteric news like this? Does anyone follow this thing that has been waiting to get in I wonder?? A million shares or more traded after hours! Food for thought. DAK

To: Biomaven who wrote (786)	1/4/2000 8:32:00 PM
From: rkrw	Respond to of 4474

As of Mid December, short interest was down significantly from peaks. I'm not endorsing Ariad, but the closing of the Aventis deal gives them a new life. Combine the cash levels with Berger's new found interest in controlling the cash burn (says it should be significantly below $10M/year) and the company now has a future. Item Ticker Company Name Month+ Shares Short Avg Daily Volume Ratio* Remark 1 ARIA ARIAD Pharmaceuticals Inc. 12/99 1,088,158 196,915 5.53 11/99 1,090,034 480,308 2.27 10/99 2,493,411 401,529 6.21 09/99 1,773,529 110,935 15.99 08/99 1,433,162 102,803 13.94 07/99 1,111,570 92,578 12.01